Related topics

MyoKardia: 3Q Earnings Snapshot

November 8, 2018

SOUTH SAN FRANCISCO, Calif. (AP) _ MyoKardia Inc. (MYOK) on Wednesday reported a loss of $15.8 million in its third quarter.

The South San Francisco, California-based company said it had a loss of 39 cents per share.

The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 50 cents per share.

The biopharmaceutical company posted revenue of $9.2 million in the period.

MyoKardia shares have risen 34 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $56.21, a climb of 45 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MYOK at https://www.zacks.com/ap/MYOK

Update hourly